Spinal Simplicity Announces FDA Clearance of Freedom Decompression System™
Spinal Simplicity has announced the FDA clearance of its Freedom Decompression System™, a minimally invasive solution for treating lumbar spinal stenosis. The system enhances procedural control and efficiency with integrated depth gauges and optimized angle management, allowing for targeted decompression and more effective patient-specific treatment options. A limited market release will begin with a controlled trial phase, leading to a full commercial launch expected later in 2026.
Spinal Simplicity announced FDA clearance of Freedom DS, a minimally invasive system for lumbar spinal stenosis designed to improve procedural control and efficiency. OVERLAND PARK, Kan., April 23, 2026 /PRNewswire-PRWeb/ — Spinal Simplicity today announced FDA clearance of the Freedom…